Company Thanks Generous Shoppers who Contributed to JDRF Campaign
Matthews, NC, 2017-May-04 — /EPR Retail News/ — Today (May 3, 2017), Harris Teeter announced its generous shoppers and valued associates raised more than $376,000 for JDRF, the leading organization funding type 1 diabetes (T1D) advocacy and research, during its March 2017 donation card campaign.
Throughout the campaign, Harris Teeter shoppers and associates were invited to make $1, $3 or $5 donations to JDRF at checkout. This year’s donation will go a long way in helping JDRF continue its mission to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications.
“Harris Teeter is overwhelmed by the generosity our shoppers and valued associates who have shown their support to JDRF,” said Danna Robinson, communication manager for Harris Teeter. “We are thankful for each of our associates and customers who joined JDRF in the fight against type 1 diabetes.”
For more information on type 1 diabetes or JDRF, please visit jdrf.org.
In T1D, a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. People with T1D need to test their blood sugar and give themselves insulin (with injections or an insulin pump) multiple times every day, and carefully balance insulin doses with eating and daily activities throughout the day and night. However, insulin is not a cure for diabetes, and even with that intensive care, a significant portion of the day is still spent with either high or low blood sugar, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, and amputation.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF
Source: Harris Teeter